Cadila Healthcare receives approval from USFDA for Zolmitriptan tablets
Cadila Healthcare has receivedΒ final approvalΒ for Zolmitriptan tablets USP, from the USFDA. The company has received final approvalΒ to market Zolmitriptan Tablets, 2.5 mg and 5 mg,...